Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1996-09-25
1998-03-03
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241851, 4241921, 435 697, 5303873, 530351, 536 234, A61K 39395, A61K 3900, C07K 1600, C07K 100
Patent
active
057231257
ABSTRACT:
Disclosed is a hybrid recombinant protein consisting of human interferon, preferably interferon-.alpha. (IFN.alpha.), and human immunoglobulin Fc fragment, preferably .gamma.4 chain, joined by a peptide linker comprising the sequence Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser (SEQ ID NO:1).
REFERENCES:
patent: 5349053 (1994-09-01), Landolfi
Huston, JS et al Methods in Enzymology vol. 203 pp. 46-88, 1991.
Chang Tse Wen
Yu Liming
Feisee Lila
Lucas John
Mirabel Eric P.
Tanox Biosystems, Inc.
LandOfFree
Hybrid with interferon-alpha and an immunoglobulin Fc linked thr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid with interferon-alpha and an immunoglobulin Fc linked thr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid with interferon-alpha and an immunoglobulin Fc linked thr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2245514